Kinfo
Aclarion Inc. logo

Aclarion Inc.

ACONNASDAQHealthcare·US · USD
$2.69
-0.15 (-5.41%)
Prices as of July 13, 2026 · market closed

Price

Key statistics

Valuation
Market cap6.62M USD
Enterprise value-12.01M USD
Trailing P/E-0.20
Forward P/E-0.52
PEG ratio0.00
Price / sales89.92
Price / book0.35
Profitability
Gross margin17.74%
Operating margin-14129.33%
Profit margin9.02%
Return on assets-28.78%
Return on equity-45.43%
Income (TTM)
Revenue77.88K USD
Gross profit15.07K USD
EBITDA-8.31M USD
Net income-8.05M USD
Diluted EPS-$5.63
Rev. growth (YoY)11.30%
Balance sheet
Total cash19.01M USD
Total debt0.00 USD
Debt / equity0.00
Current ratio19.65
Book value / share$8.04
Cash flow (TTM)
Operating cash flow-7.30M USD
Levered free cash flow-4.90M USD
Shares & price
Shares outstanding2.44M
Float2.20M
Held by institutions4.35%
Beta1.21
50-day MA$3.15
200-day MA$4.61
52-week high$12.03
52-week low$2.34
Dividends
Forward rate
$4.00
Yield
148.70%
Payout ratio
0.00%
Frequency
Annual
Recent payments
  • 2021-03-26$5,360.00
Earnings (EPS)
DateEst.ActualSurprise2026-06-25-0.34-0.39−14.71%2026-05-13-1.55-1.34+13.55%2026-03-170.420.65+54.76%2025-12-11-2.13-0.32+84.98%
About Aclarion Inc.

Aclarion Inc. is a healthcare technology company that develops innovative diagnostic solutions for spine-related conditions, particularly low back and neck pain. The company combines magnetic resonance spectroscopy (MRS) imaging with proprietary augmented-intelligence algorithms to create software-as-a-service (SaaS) solutions that help physicians personalize treatment plans and optimize clinical outcomes. The company's primary offering is the NOCISCAN Suite, which uses MRS capabilities to noninvasively analyze the chemical composition of intervertebral discs in the spine. Aclarion's suite includes the NOCISCAN MRS Exam Protocol for standard lumbar MRI exams, the NOCISCAN Post-Processor Suite with NOCICALC and NOCIGRAM applications that process spectroscopy data and calculate degenerative pain biomarkers, and complementary imaging data transfer platforms. By leveraging artificial intelligence to assist in quality control processes and proprietary biomarkers, Aclarion aims to address unmet clinical needs in musculoskeletal pain management and help patients achieve improved health outcomes and pain relief.

Sector
Healthcare
Industry
Health Information Services
CEO
Mr. Brent Ness
Employees
10
Headquarters
Broomfield, CO, United States

Frequently asked questions about Aclarion Inc.